We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
-1.09%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.68B
AUM Growth
-$375M
Cap. Flow
-$261M
Cap. Flow %
-7.11%
Top 10 Hldgs %
10.92%
Holding
331
New
26
Increased
99
Reduced
137
Closed
37

Top Buys

Rank Stock Value
1
OMCL icon
Omnicell
OMCL
+$19.6M
2
ATKR icon
Atkore
ATKR
+$18.3M
3
VRRM icon
Verra Mobility
VRRM
+$18.1M
4
PLMR icon
Palomar
PLMR
+$14.1M
5
BLUE
bluebird bio
BLUE
+$13.8M

Top Sells

Rank Stock Value
1
GWR
Genesee & Wyoming Inc.
GWR
+$31.1M
2
CPRT icon
Copart
CPRT
+$29.6M
3
ARRY
Array Biopharma Inc
ARRY
+$25.2M
4
NEWR
New Relic, Inc.
NEWR
+$18.7M
5
CBLK
Carbon Black, Inc. Common Stock
CBLK
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 22.75%
2 Healthcare 18.85%
3 Financials 15.11%
4 Industrials 13.13%
5 Consumer Discretionary 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DY icon
126
Dycom Industries
DY
$12B
$11.9M 0.32%
232,772
+7,657
+3% +$386K
IOVA icon
127
Iovance Biotherapeutics
IOVA
$2.9B
$11.7M 0.32%
643,415
-14,236
-2% -$315K
IONS icon
128
Ionis Pharmaceuticals
IONS
$9.46B
$11.6M 0.32%
194,329
+6,768
+4% +$441K
IMMU
129
DELISTED
Immunomedics Inc
IMMU
$11.4M 0.31%
+860,623
New +$12.7M
NVCR icon
130
NovoCure
NVCR
$2.02B
$11.4M 0.31%
151,942
-50,675
-25% -$4.05M
VIRT icon
131
Virtu Financial
VIRT
$4.92B
$11.3M 0.31%
691,486
+22,586
+3% +$452K
ICPT
132
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$11.1M 0.3%
167,902
+38,556
+30% +$2.59M
EVH icon
133
Evolent Health
EVH
$444M
$11M 0.3%
1,530,763
+405,993
+36% +$2.91M
IRWD icon
134
Ironwood Pharmaceuticals
IRWD
$669M
$10.9M 0.3%
1,274,690
+41,908
+3% +$407K
VC icon
135
Visteon
VC
$2.8B
$10.9M 0.3%
132,526
-30,422
-19% -$2.03M
LKFT
136
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$10.9M 0.3%
71,442
-4,706
-6% -$771K
CCS icon
137
Century Communities
CCS
$1.96B
$10.9M 0.3%
354,983
-82,239
-19% -$2.29M
MNTA
138
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$10.8M 0.29%
832,627
+27,377
+3% +$331K
BLUE
139
DELISTED
bluebird bio
BLUE
$10.7M 0.29%
+9,017
New +$13.8M
FLXN
140
DELISTED
Flexion Therapeutics, Inc.
FLXN
$10.7M 0.29%
781,377
+25,603
+3% +$304K
CERS icon
141
Cerus
CERS
$508M
$10.5M 0.28%
2,027,455
-167,173
-8% -$896K
CBLK
142
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$10.4M 0.28%
400,528
-762,775
-66% -$16.8M
OPLN
143
Openlane
OPLN
$4.58B
$10.4M 0.28%
423,056
-31,795
-7% -$814K
VCRA
144
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$10.3M 0.28%
417,629
+88,704
+27% +$2.3M
TPC
145
Tutor Perini Cor
TPC
$5.18B
$10M 0.27%
699,968
+211,122
+43% +$2.58M
BNFT
146
DELISTED
Benefitfocus, Inc.
BNFT
$9.92M 0.27%
416,750
+13,776
+3% +$353K
ABG icon
147
Asbury Automotive
ABG
$3.78B
$9.31M 0.25%
90,992
-20,997
-19% -$1.94M
WGO icon
148
Winnebago Industries
WGO
$906M
$9.28M 0.25%
241,960
-55,490
-19% -$2.02M
DEA
149
Easterly Government Properties
DEA
$1.13B
$9.15M 0.25%
171,801
-39,711
-19% -$1.97M
KN icon
150
Knowles
KN
$3.27B
$9.06M 0.25%
445,557
-160,981
-27% -$3.16M
4 5
6
7 8

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return

Peregrine Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Peregrine Capital Management held 331 positions worth $3.68B, down 9.3% from $4.05B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Peregrine Capital Management withdrew a net $261M in Q3 2019, closing 37 positions and reducing 137 holdings. Its most notable exit was Genesee & Wyoming Inc., an estimated $31.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peregrine Capital Management opened a new position in Atkore worth $19.8M.

  • Peregrine Capital Management's largest Q3 2019 buy was Atkore: 651,484 shares worth $19.8M.
  • Peregrine Capital Management added most to Omnicell in Q3 2019, an estimated $19.6M increase.
  • Peregrine Capital Management's biggest Q3 2019 reduction was Copart, cutting an estimated $29.6M.
  • Peregrine Capital Management fully exited Genesee & Wyoming Inc. in Q3 2019, selling an estimated $31.1M.
  • Peregrine Capital Management's ten largest holdings make up 11% of its $3.68B portfolio in Q3 2019.
  • Peregrine Capital Management opened 26 new positions and closed 37 in Q3 2019.
  • Peregrine Capital Management's portfolio value fell 9.3% quarter-over-quarter to $3.68B.

Based on Peregrine Capital Management's 13F filing for Q3 2019, filed 16 Oct 2019.